Labviva, an AI-driven life sciences digital marketplace, has raised $20 million in Series A financing led by Biospring Partners, with participation from existing investors Senator Investment Group, B Capital Group, and Glasswing Ventures.
The funds will be used to accelerate deployment of Labviva’s platform at a number of global pharmaceutical and academic customers, expand its global footprint, launch new and complementary product lines, and increase its supplier base.
Labviva’s platform unifies the interface for product discovery and procurement, seamlessly connecting suppliers and purchasers and enabling scientists to make better purchasing decisions. The platform integrates directly with leading procurement systems to shorten implementation times and reduce the risk of research delays.
Give a Pawfive to this post!
Share with your friends and followers
Start writing about what excites you in tech — connect with developers, grow your voice, and get rewarded.
Join other developers and claim your FAUN.dev() account now!
